de Koning H - Search Results

1

Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.

Puliti D, Duffy SW, Miccinesi G, de Koning H, Lynge E, Zappa M, Paci E; EUROSCREEN Working Group. Puliti D, et al. Among authors: de koning h. J Med Screen. 2012;19 Suppl 1:42-56. doi: 10.1258/jms.2012.012082. J Med Screen. 2012. PMID: 22972810 Review.

2

A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy.

Paci E, Boer R, Zappa M, de Koning HJ, van Oortmarssen GJ, Crocetti E, Giorgi D, Rosselli del Turco M, Habbema JD. Paci E, et al. Among authors: de koning hj. Eur J Cancer. 1995;31A(3):348-53. doi: 10.1016/0959-8049(95)94001-f. Eur J Cancer. 1995. PMID: 7786600

3

Radiation risk of mammography related to benefit in screening programmes: a favourable balance?

Beemsterboer PM, Warmerdam PG, Boer R, de Koning HJ. Beemsterboer PM, et al. Among authors: de koning hj. J Med Screen. 1998;5(2):81-7. doi: 10.1136/jms.5.2.81. J Med Screen. 1998. PMID: 9718526

4

Psychosocial predictors of first attendance for organised mammography screening.

Aro AR, de Koning HJ, Absetz P, Schreck M. Aro AR, et al. Among authors: de koning hj. J Med Screen. 1999;6(2):82-8. doi: 10.1136/jms.6.2.82. J Med Screen. 1999. PMID: 10444726 Clinical Trial.

5

Trends in mammography 1991-96 and the impact of nationwide screening in The Netherlands.

van Leiden HA, van Gessel-Dabekaussen AA, van der Maas PJ, de Koning HJ. van Leiden HA, et al. Among authors: de koning hj. J Med Screen. 1999;6(2):94-8. doi: 10.1136/jms.6.2.94. J Med Screen. 1999. PMID: 10444728

6

PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer.

Otto SJ, Moss SM, Määttänen L, Roobol M, Zappa M, Nelen V, Kwiatkowski M, Villers A, Hugosson J, Sanchez AB, de Koning HJ. Otto SJ, et al. Among authors: de koning hj. Eur J Cancer. 2010 Nov;46(17):3053-60. doi: 10.1016/j.ejca.2010.09.012. Eur J Cancer. 2010. PMID: 21047586

7

International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report.

Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, Pedersen JH, Swanson SJ, Travis WD, Wisbuba II, Noguchi M, Mulshine JL; IASLC CT Screening Workshop 2011 Participants. Field JK, et al. J Thorac Oncol. 2012 Jan;7(1):10-9. doi: 10.1097/JTO.0b013e31823c58ab. J Thorac Oncol. 2012. PMID: 22173661 Free article.

8

The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies.

Moss SM, Nyström L, Jonsson H, Paci E, Lynge E, Njor S, Broeders M; Euroscreen Working Group. Moss SM, et al. J Med Screen. 2012;19 Suppl 1:26-32. doi: 10.1258/jms.2012.012079. J Med Screen. 2012. PMID: 22972808 Review.

9

Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies.

Njor S, Nyström L, Moss S, Paci E, Broeders M, Segnan N, Lynge E; Euroscreen Working Group. Njor S, et al. J Med Screen. 2012;19 Suppl 1:33-41. doi: 10.1258/jms.2012.012080. J Med Screen. 2012. PMID: 22972809 Review.

10

European randomized lung cancer screening trials: Post NLST.

Field JK, van Klaveren R, Pedersen JH, Pastorino U, Paci E, Becker N, Infante M, Oudkerk M, de Koning HJ; European Randomized Screening Trial Group. Field JK, et al. Among authors: de koning hj. J Surg Oncol. 2013 Oct;108(5):280-6. doi: 10.1002/jso.23383. Epub 2013 Jul 25. J Surg Oncol. 2013. PMID: 23893464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

776 results

Search Page